SBIR/STTR Research Award

SURFACE MODIFICATION OF BIOMATERIALS FOR THROMBOSIS PREVENTION

Award identifier 55e7b2280384257399e823b5428183c07b9a280a4b2706cb4ed71572bc9f3992Awarding agency Department of Health and Human Services

Award amount

$500,000

Program and phase

SBIR · Phase II

Award year

1992

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
SURMODICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

ALL SYNTHETIC MATERIALS THAT CONTACT BLOOD EXPERIENCE PROBLEMS WITH BLOOD COMPATIBILITY. THE RAPID ADSORPTION OF PLASMA PROTEINS AND SUBSEQUENT ADHERENCE AND ACTIVATION OF PLATELETS LEADS TO THROMBUS FORMATION. WHEN PATIENTS ARE IMPLANTED WITH VASCULAR DEVICES OR UNDERGO HEMODIALYSIS PROCEDURES, MAINTENANCE LEVELS OF ANTICOAGULANTS MUST BE GIVEN TO PREVENT LIFE-THREATENING CLOT FORMATIONS. HOWEVER, THESE DRUGS HAVE VERY DANGEROUS SIDE EFFECTS. PREPARATION OF NONTHROMBOGENIC-DEVICE POLYMERS WOULD REDUCE THE NEED FOR SUCH HIGH LEVELS OF THESE DRUGS. THIS PROJECT WILL USE PHOTOCHEMICAL COUPLING REAGENTS TO SURFACE-MODIFY BIOMEDICAL DEVICE MATERIALS FOR THROMBOSIS PREVENTION. HYDROPHILIC MATERIALS WILL BE IMMOBILIZED TO PREVENT PLASMA PROTEIN DEPOSITION, AND HEPARIN WILL BE ATTACHED TO THE ENDS OF THESE SPACERS TO GIVE THE SURFACE ANTICOAGULANT ACTIVITY. PHOTOCHEMISTRY IS CHOSEN BECAUSE THIS CHEMISTRY ALLOWS GENERIC COUPLING TO A WIDE RANGE OF MEDICAL DEVICE POLYMERS. SEVERAL PHOTOACTIVATIBLE REAGENTS WILL BE PREPARED, AND THEN THE PHOTOIMMOBILIZATION OF THESE REAGENTSTO RELEVANT MATERIALS WILL BE DEMONSTRATED. IN VITRO ANTICOAGULANT AND PLATELET ADHERENCE AND ACTIVATION ASSAYS WILL BE CONDUCTED TO EVALUATE THE EFFICACIES OF THE MODIFIED SURFACES. THESE IN VITRO ANALYSES WILL LEAD TO ADDITIONAL CHEMISTRY OPTIMIZATION AND EX VIVO SHUNT TESTING OF THROMBOGENICITY AND HEMOCOMPATIBILITY IN PHASE II.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.